Literature DB >> 26148972

Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65.

Liron Abuhatzira1, Huanyu Xu2, Georges Tahhan2, Afroditi Boulougoura2, Alejandro A Schäffer2, Abner L Notkins2.   

Abstract

Islet antigen (IA)-2, IA-2β, and glutamate decarboxylase (GAD65) are major autoantigens in type 1 diabetes (T1D). Autoantibodies to these autoantigens appear years before disease onset and are widely used as predictive markers. Little is known, however, about what regulates the expression of these autoantigens. The present experiments were initiated to test the hypothesis that microRNAs (miRNAs) can target and affect the levels of these autoantigens. Bioinformatics was used to identify miRNAs predicted to target the mRNAs coding IA-2, IA-2β, and GAD65. RNA interference for the miRNA processing enzyme Dicer1 and individual miRNA mimics and inhibitors were used to confirm the effect in mouse islets and MIN6 cells. We show that the imprinted 14q32 miRNA cluster contains 56 miRNAs, 32 of which are predicted to target the mRNAs of T1D autoantigens and 12 of which are glucose-sensitive. Using miRNA mimics and inhibitors, we confirmed that at least 7 of these miRNAs modulate the mRNA levels of the T1D autoantigens. Dicer1 knockdown significantly reduced the mRNA levels of all 3 autoantigens, further confirming the importance of miRNAs in this regulation. We conclude that miRNAs are involved in regulating the expression of the major T1D autoantigens. © FASEB.

Entities:  

Keywords:  autoimmune diabetes; glucose-sensitive; miR-342; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26148972      PMCID: PMC4566937          DOI: 10.1096/fj.15-273649

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  47 in total

1.  A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain.

Authors:  Hervé Seitz; Hélène Royo; Marie-Line Bortolin; Shau-Ping Lin; Anne C Ferguson-Smith; Jérôme Cavaillé
Journal:  Genome Res       Date:  2004-08-12       Impact factor: 9.043

2.  Isolation and culture of mouse pancreatic islets for ex vivo imaging studies with trappable or recombinant fluorescent probes.

Authors:  Magalie A Ravier; Guy A Rutter
Journal:  Methods Mol Biol       Date:  2010

3.  The imprinting box of the Prader-Willi/Angelman syndrome domain.

Authors:  R Shemer; A Y Hershko; J Perk; R Mostoslavsky; B Tsuberi; H Cedar; K Buiting; A Razin
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

4.  Nonviral transfection of intact pancreatic islets.

Authors:  J R Lakey; A T Young; D Pardue; S Calvin; T E Albertson; L Jacobson; T J Cavanagh
Journal:  Cell Transplant       Date:  2001       Impact factor: 4.064

5.  The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers.

Authors:  Masayo Kagami; Maureen J O'Sullivan; Andrew J Green; Yoshiyuki Watabe; Osamu Arisaka; Nobuhide Masawa; Kentarou Matsuoka; Maki Fukami; Keiko Matsubara; Fumiko Kato; Anne C Ferguson-Smith; Tsutomu Ogata
Journal:  PLoS Genet       Date:  2010-06-17       Impact factor: 5.917

Review 6.  New pancreas from old: microregulators of pancreas regeneration.

Authors:  Mugdha V Joglekar; Vishal S Parekh; Anandwardhan A Hardikar
Journal:  Trends Endocrinol Metab       Date:  2007-12       Impact factor: 12.015

7.  Inflammation-Mediated Regulation of MicroRNA Expression in Transplanted Pancreatic Islets.

Authors:  Valia Bravo-Egana; Samuel Rosero; Dagmar Klein; Zhijie Jiang; Nancy Vargas; Nicholas Tsinoremas; Marco Doni; Michele Podetta; Camillo Ricordi; R Damaris Molano; Antonello Pileggi; Ricardo L Pastori
Journal:  J Transplant       Date:  2012-05-10

8.  microRNA target predictions across seven Drosophila species and comparison to mammalian targets.

Authors:  Dominic Grün; Yi-Lu Wang; David Langenberger; Kristin C Gunsalus; Nikolaus Rajewsky
Journal:  PLoS Comput Biol       Date:  2005-06-24       Impact factor: 4.475

9.  Clustering and conservation patterns of human microRNAs.

Authors:  Yael Altuvia; Pablo Landgraf; Gila Lithwick; Naama Elefant; Sébastien Pfeffer; Alexei Aravin; Michael J Brownstein; Thomas Tuschl; Hanah Margalit
Journal:  Nucleic Acids Res       Date:  2005-05-12       Impact factor: 16.971

10.  Study on Genetic Variance of miR-541 in Type 1 Diabetes.

Authors:  Bei Han; Xing Shi; Quan Peng; Wentao Gao
Journal:  ISRN Endocrinol       Date:  2012-12-11
View more
  12 in total

Review 1.  miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.

Authors:  Ying Zheng; Zhen Wang; Zhiguang Zhou
Journal:  Cell Mol Immunol       Date:  2017-03-20       Impact factor: 11.530

2.  Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.

Authors:  Isaac V Snowhite; Gloria Allende; Jay Sosenko; Ricardo L Pastori; Shari Messinger Cayetano; Alberto Pugliese
Journal:  Diabetologia       Date:  2017-05-12       Impact factor: 10.122

3.  miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes.

Authors:  Giuliana Ventriglia; Francesca Mancarella; Guido Sebastiani; Dana P Cook; Roberto Mallone; Chantal Mathieu; Conny Gysemans; Francesco Dotta
Journal:  Diabetologia       Date:  2019-10-28       Impact factor: 10.122

4.  Baseline Assessment of Circulating MicroRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Secretion.

Authors:  Isaac Snowhite; Ricardo Pastori; Jay Sosenko; Shari Messinger Cayetano; Alberto Pugliese
Journal:  Diabetes       Date:  2020-12-04       Impact factor: 9.461

Review 5.  Innate Viral Sensor MDA5 and Coxsackievirus Interplay in Type 1 Diabetes Development.

Authors:  Samuel I Blum; Hubert M Tse
Journal:  Microorganisms       Date:  2020-07-03

6.  Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study.

Authors:  L J Smyth; J Kilner; V Nair; H Liu; E Brennan; K Kerr; N Sandholm; J Cole; E Dahlström; A Syreeni; R M Salem; R G Nelson; H C Looker; C Wooster; K Anderson; G J McKay; F Kee; I Young; D Andrews; C Forsblom; J N Hirschhorn; C Godson; P H Groop; A P Maxwell; K Susztak; M Kretzler; J C Florez; A J McKnight
Journal:  Clin Epigenetics       Date:  2021-05-01       Impact factor: 6.551

7.  Small cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2.

Authors:  Huanyu Xu; Tao Cai; Gilberto N Carmona; Liron Abuhatzira; Abner L Notkins
Journal:  J Transl Med       Date:  2016-09-26       Impact factor: 5.531

8.  Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.

Authors:  Linda Åkerman; Rosaura Casas; Johnny Ludvigsson; Beatriz Tavira; Camilla Skoglund
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

9.  MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.

Authors:  Taís S Assmann; Mariana Recamonde-Mendoza; Bianca M De Souza; Daisy Crispim
Journal:  Endocr Connect       Date:  2017-10-06       Impact factor: 3.335

Review 10.  Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors.

Authors:  Lilla Krokker; Attila Patócs; Henriett Butz
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.